Scientific Advisors
Dr. Jay Fishman
Dr. Jay A. Fishman is Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH) and Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts. He is an Attending Physician in the Infectious Disease Division of the MGH.
Dr. Fishman received his B.A. degree magna cum laude from the University of Pennsylvania (1975) and the M.D. degree from Johns Hopkins University School of Medicine (1979). He completed his Residency in Internal Medicine and Fellowship in Infectious Diseases at the MGH. He completed post-doctoral fellowship training in Molecular Biology and Genetics at the MGH and Harvard Medical School investigating molecular cloning of surface antigens of Pneumocystis carinii. He received additional training in Molecular Parasitology at the Yale University School of Medicine. He joined the staff of the Infectious Disease Division at MGH in 1985.
Dr. Fishman's clinical and research interests focus on the pathogenesis and prevention of infection in the immunocompromised host. His laboratory is investigating infectious disease issues related to xenotransplantation, including the first cloning of porcine endogenous retrovirus from miniature swine, studies of porcine herpesviruses in xenotransplant models, and the examination of immune responses following xenogeneic immune reconstitution. This laboratory is also studying mechanisms of fungal infection and combinations of antifungal agents in animal models. Clinical research includes studies of new antimicrobial strategies for the prevention of fungal and cytomegalovirus infection in solid organ and hematopoietic transplantation recipients. His research is funded by both NIH and corporate grants. He is the author of over 100 peer-reviewed publications.
Dr. Fishman is President-elect of the American Society of Transplantation - the first Infectious Disease physician to serve in this capacity. He is a Fellow of the Infectious Disease Society of America and of the American College of Physicians. He is Associate Editor of the American Journal of Transplantation and Transplant Infectious Diseases. He has served on several NIH advisory committees and national and international data safety monitoring boards for transplantation and the Immune Tolerance Network. Dr. Fishman has lectured and published extensively on infection in immune compromised hosts, on viral and fungal infections, on the pathogenesis of pneumonia, and on the infectious risks and benefits associated with xenotransplantation.
Dr. David Hillyard
David R. Hillyard is Associate Professor of Pathology at the University of Utah School of Medicine. He received his M.D. degree from the Columbia University College of Physicians and Surgeons in 1977. He completed his Residency in Pathology at St. Luke’s Roosevelt Hospital Center in New York and a Postdoctoral Fellowship in Medical Microbiology and Microbial Genetics at the University of Utah.
Dr. Hillyard is co-editor on the Handbook of Molecular Pathology (2007). He is the author of over fifty peer-reviewed publications and has reviewed Journal articles and contributed Book Chapters. He was Principal Investigator on two research grants awarded by the National Science Foundation and the United States Agency for International Development. In addition to his research work and clinical teaching, Dr. Hillyard has presented at National conferences and meetings on various topics including the “Validation of quantitative real-time assays” and “Addressing the genetic diveristy of HCV by real-time PCR.”
Dr Hillyard is Medical Director of the molecular infectious diseases section, the molecular hepatitis/retrovirus section, and the molecular sequencing section of the Molecular Pathology Laboratory at ARUP. The ARUP Institute for Clinical and Experimental Pathology, founded by members of the Department of Pathology at the University of Utah, was designed to transition University-based research into practical applications.